Ace Vision Group Names Rob Kissling, MD, as Chief Medical Officer
Ace Vision Group announced that it has named Rob Kissling, MD, as Chief Medical Officer.
Dr. Kissling has more than 20 years of experience integrating clinical development, medical strategy, and business planning to develop and commercialize devices and medicines for ophthalmology. His tenure has included companies such as Pharmacia, Pfizer, and Novartis. Most recently, he served as Vice President of Clinical and Medical Affairs at Bausch + Lomb, where he oversaw medical development of the company’s pharmaceutical, surgical, and consumer product portfolio.
Explore More Articles
Ocular Health Implications of the Loss of Dynamic Range of Focus Function in Presbyopia
Presbyopia is defined as the eye’s loss of ability to focus on objects at near distances, and it is the most common cause of age-related vision impairment. Presbyopia is a significant global health issue that is underdiagnosed. It affects all people in their 40s and older: an estimated 90 million people in the United States …
read moreVIDEO: Ace Vision Group provides update on presbyopia laser development
SAN FRANCISCO — In this Healio Video Perspective from Eyecelerator@AAO, AnnMarie Hipsley, DPT, PhD, and Alex Lopez of Ace Vision Group provide an update on the development of the VisioLite ophthalmic laser for presbyopia. The company is in a Series B2 round of funding.
read morePathogenesis of Presbyopia: A New Understanding of an Age-Old Disease
FOR MOST OF HISTORY, PRESBYOPIA has been defined as a “normal” refractive error caused by age, with discussion limited to the loss of near vision beginning in our 40s. Because we have had no effective therapeutic interventions available, presbyopia has been accepted as a natural part of life and treated primarily by changing power at either …
read more